Table 1

Characteristics of the selected studies included in the meta-analysis BV - HPV

Year of publication

Authors

Country

Study Design

Nr cases enrolled

Participants

Age range (Years)

HPV Diag

HPV Prev (%)

BV Diag

BV Prev (%)


1995

Peters et al[18]

Netherlands

CS

280

referred

20 - 66

PCR

71.1

Mod Amsel

20.0

1997

Sikström et al[20]

Sweden

CS

972

attendees

-

FISH

6.8

Amsel

13.0

2001

Castle et al[21]

Costa Rica

CS

8582

screened

-

PCR

59.6

Nugent

37.8

2003

Mao et al[23]

USA

FU

516

screened

18 - 24

PCR

22.8

Amsel

3.0

2003

Boyle et al[22]

UK

CS

379

attendees

16 - 58

PCR

21.1

Amsel

30.9

2004

da Silva et al[14]

Brazil

CS

52

attendees

15 - 35

PCR

50.0

Amsel

34.6

2005

Watts et al[17]*

USA

CS

2229

attendees (HIV and high-risk)

-

PCR

56.1

Nugent

43.7

2005

Samoff et al[24]*

USA

FU

151

attendees

13 - 19

PCR

53.5

Nugent

47.2

2008

Figueiredo et al[15]

Brazil

CS

228

referred

-

PCR

84.2

Clue cells

17.0

2009

Verteramo et al[26]

Italy

CS

857

attendees

17 - 58

PCR

31.0

Amsel

6.3

2009

Nam et al[25]

South-Korea

CS

510

referred

-

PCR

69.1

Amsel

11.0

2009

Rahkola et al[13]

Finland

CS

328

mix

18 - 69

PCR

53.3

Clue cells

15.2


** Prevalence and incidence study

Abbreviations: HPV = Human Papillomavirus; BV = Bacterial vaginosis, PCR = Polymerase Chain Reaction, FISH = Fluorescent In Situ Hybridization, CS = Cross-sectional study, FU = Follow-up study, Diag = diagnosis, Prev = Prevalence

Participants: referred (women referred to colposcopy clinic because of abnormal Pap-smear), attendees (women attending family planning or obstetrics and gynaecology clinics), screened (population sample, screening), mix (referred, attendees and/or screened)

Gillet et al. BMC Infectious Diseases 2011 11:10   doi:10.1186/1471-2334-11-10

Open Data